Rebound hyperbilirubinemia in a sample of newborns with jaundice
DOI:
https://doi.org/10.56056/amj.2019.108Keywords:
Neonates, Phototherapy, Rebound jaundiceAbstract
Background and objectives: Neonatal jaundice represents a prevalent public health problem in Erbil city. Rebound jaundice after termination of phototherapy is common and related to many factors, so the aim of the study is to estimate the prevalence of rebound jaundice among neonates after termination of phototherapy and identifying any associated factors.
Method:A cross sectional study was conducted in Neonatal Care Unit of Raparin Teaching Hospital in Erbil during the period from 1st of September, 2018 to 28th of February, 2019 on sample of 100 neonates with jaun- dice. The selected neonates were followed for up to 72 hours after discharge from hospital. Total serum bilirubin levels of neonates were measured at admission, on discharge and within 72 hours of phototherapy termination.
Results:The rebound jaundice was present in 20% of neonates after stopping the phototherapy. Those were significantly related to certain socioeconomic and clinical data like (male gender, prematurity, low birth weight, Glucose-6-phosphate de- hydrogenase deficiency, higher total serum bilirubin at admission, lower total serum bilirubin at discharge, low hemo- globin, high reticulocyte counts and shorter phototherapy duration).
Conclusions:The prevalence of rebound jaundice after termination of phototherapy was high. So follow up is mandatory within 72 hours of phototherapy termination.
Downloads
References
Jodeiry B, Fkhraee S-H, Kazemian M, Afjeiee S-A, Javaherizadeh H. Rebound hyperbilirubinaemia in neonates admitted to Mofid Children’s Hospital, Tehran, Iran. South African Journal of Child Health. 2013; 7 (1): 22-4. Available at: http://www.sajch.org.za/index.php/SAJCH/article/ view/428/381.
American Academy of Pediatrics Subcommittee on Hyperbilirubine-mia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114(1):297–316.
National Institute for Health and Care Excellence. Neonatal jaundice (NICE Clinical Guideline 98). London, England: National Institute for Health and Clinical Excellence; 2010. Available at: https://www.nice. org.uk/guidance/cg98.
Shaker NZ. Disease Patterns and outcomes of Neonatal Admissions at Raparin Pediatric Teaching Hospital in Erbil City. Iraqi National Jour- nal of Nursing Specialties. 2015; 28 (2): 39-46.
Chang PW, Kuzniewicz MW, McCulloch CE, Newman TB. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy. Pediatrics. 2017; 139 (3): e20162896.
Sharba SA. Adverse Effects and Rebound Increase in Bilirubin Lev- el: Comparison between Conventional Versus Intensive Phototherapy. Medical Journal of Babylon. 2015; 12 (1): 17-23.
Niknafs N, Nili F, Dalili H, Nayeri F, Esmaeilnia T, Amini EA. Comparison of Significant Bilirubin Rebound after Discontinuation of Phototherapy in Two Groups of Neonates in Valiasr Hospital: A Randomized Clinical Trial. IJN. 2014; 4(4): 17-21.
Kaplan M, Kaplan E, Hammerman C. Post-phototherapy neonatal bilirubin rebound: a potential cause of significant hyperbilirubinaemia. Arch Dis Child. 2006; 91(1):31–4.
Erdeve O, Tiras U, Dallar Y. Rebound bilirubin measurement is not required for hyperbilirubinemia regardless of the background attributes of newborns. J Trop Pediatr. 2004; 50(5):309.
Barak M, Berger I, Dollberg S, Mimouni FB, Mandel D. When should phototherapy be stopped? A pilot study comparing two targets of serum bilirubin concentration. Acta Paediatr. 2009; 98(2):277–81.
Maisels MJ, Kring E. Rebound in serum bilirubin level following in- tensive phototherapy. Arch Pediatr Adolesc Med 2002; 156: 669-72.
van Kaam AH, van Beek RH, Vergunst-van Keulen JG, et al. Fibre op- tic versus conventional phototherapy for hyperbilirubinaemia in preterm infants. Eur J Pediatr. 1998; 157:132-7.
Silva I, Luco M, Tapia JL, et al. Single vs. double phototherapy in the treatment of full-term newborns with nonhemolytic hyperbilirubinemia. J Pediatr (Rio J). 2009; 85(5):455-8.
Elhawary IM, Abdel Ghany EAG, Aboelhamed WA, Ibrahim SGE. In- cidence and risk factors of post-phototherapy neonatal rebound hyper- bilirubinemia. World J Pediatr. 2018; 14(4):350-6.
Berkwitt A, Osborn R, Grossman M. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyper- bilirubinemia. Hosp Pediatr. 2015; 5(2):74-8.
Valinjkar SK, Sutay NR, Sharma B. Rebound Hyperbilirubinemia in Neonates after Phototherapy and Factors Affecting It. JMSCR. 2017; 05 (03): 19003-14.
Bansal A, Jain S, Parmar VR, Chawla D. Bilirubin rebound after intensive phototherapy for neonatal jaundice. Indian Pediatr. 2010; 47(7):607–9.
Facchini FP, Mezzacappa MA, Rosa IR, Mezzacappa Filho F, Ara- nha-Netto A, Marba ST. Follow-up of neonatal jaundice in term and late premature newborns. J Pediatr (Rio J). 2007; 83(4):313-22.
Soni R, Kaushik SL, Kaushik R, Bhardwaj P, Mohabey S. Post pho- totherapy bilirubin rebound: incidence and risk factors. Int J Res Med Sci. 2017; 5:4112-6.
Woodgate P, Jardine LA. Neonatal jaundice. BMJ Clin Evid. 2011; 2011:0319.
Yurdakök M. Phototherapy in the newborn: what’s new? Proceed- ings of the 11th International Workshop on Neonatology and Satellite Meetings Cagliari (Italy) 2015. Journal of Pediatric and Neonatal Indi- vidualized Medicine. 2015; 4 (2):1-26.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Iman Akram Hamad, Dlair Abdulkhaliq Chalabi
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The copyright on any article published in AMJ (The Scientific Journal of Kurdistan Higher Council of Medical Specialties )is retained by the author(s) in agreement with the Creative Commons Attribution Non-Commercial ShareAlike License (CC BY-NC-SA 4.0)
